Gryphon Bio Inc

Gryphon Bio Inc. is a small, early-stage biotechnology company based in South San Francisco, California. Founded by researchers with over two decades of experience in brain proteomics, Gryphon Bio employs a team of five dedicated individuals. The company generated $2.5 million in revenue in its recent fiscal year. Gryphon Bio specializes in developing novel therapeutic targets and blood biomarkers for brain health based on the discovery of significant waves of brain molecules in the blood. Their research focuses on identifying brain-specific proteins with blood levels that fluctuate over time, providing valuable insights into brain function and potential disease states. The company's mission is to pioneer diagnostic-powered therapeutics for brain health, aiming to translate their scientific discoveries into effective treatments for patients. Gryphon Bio envisions a future where diagnostics play a central role in personalized medicine for the brain, leading to improved patient outcomes. For more information about Gryphon Bio Inc., please visit their website at gryphonbio.com.